Hee-Young Park, PhD Hear my name
Boston University Chobanian & Avedisian School of Medicine
Dept of Medical Sciences & Education

PhD, Massachusetts Institute of Technology

Pronouns: she/her/hers

Dr. Hee-Young Park is a Professor and Chair of Medical Sciences & Education department at BUSM. She additional holds an administrative role as the Associate Dean of Faculty Affairs and oversees the faculty appointments and promotions at BUSM, as well as many other faculty related activities. Dr. Park received both B.S. and Ph.D. degrees from MIT and spent first 2 decades of her professional career as a biomedical researcher. Dr. Park’s research was focused on signaling pathways and factors that control skin color, aging and cutaneous wound healing. Specifically, she has made seminal contribution in these fields by discovering and characterizing the key role of serine/threonine kinases that turn on and off key enzymes and transcription factors. In addition to her research activities, she has consulted cosmetic and pharmaceutical companies interested in developing treatments for pigmentation-disorders and holds a patent for a method to decrease skin pigmentation. Dr. Park also has a long-standing interest in teaching and mentoring students. She has served as a faculty advisor and mentor to graduate students, medical students, residents and post-doctoral fellows.

Boston University Chobanian & Avedisian School of Medicine
Dermatology (excluding Mohs Surgery)

Associate Dean for Faculty Affairs
Boston University Chobanian & Avedisian School of Medicine
Dean’s Office

Boston University Chobanian & Avedisian School of Medicine
Medical Sciences & Education

Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

The Ability of Dermagraft to Stimulate Proliferation of Dermal Fibroblasts and Suppress Growth Inhibitory Activity of Chronic Wound Fluid
08/03/2004 - 02/28/2006 (PI)
Smith & Nephew

Proposal for Phase V Study
05/01/2001 - 12/31/2003 (PI)
Augustine Medical Devices Inc

Activation of Tyrosinase in Human Melanogenesis
03/15/1997 - 12/31/2001 (PI)
NIH/National Cancer Institute
5 R01 CA72763 04

The Effects of the Augustine Medical Wound Care Device on the Inhibitory Effects of Chronic Wound Fluid Upon Fibroblasts In Vitro.
09/01/1996 - 04/30/2001 (PI)
Augustine Medical Inc (formerly Augustine Medical Devices Inc)


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Park HY, Berkowitz O, Symes K, Dasgupta S. The art and science of selecting graduate students in the biomedical sciences: Performance in doctoral study of the foundational sciences. PLoS One. 2018; 13(4):e0193901.View Related Profiles. PMID: 29614110; PMCID: PMC5882097; DOI: 10.1371/journal.pone.0193901;
  2. Mitchell B, Leone D, Feller JK, Bondzie P, Yang S, Park HY, Mahalingam M. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status. Melanoma Res. 2014 Dec; 24(6):621-5.View Related Profiles. PMID: 25211166; DOI: 10.1097/CMR.0000000000000120;
  3. Belisle ES, Park HY. Metformin: a potential drug to treat hyperpigmentation disorders. J Invest Dermatol. 2014 Oct; 134(10):2488-91. PMID: 25219649; DOI: 10.1038/jid.2014.245;
  4. Mitchell B, Leone D, Feller K, Menon S, Bondzie P, Yang S, Park HY, Mahalingam M. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility? Hum Pathol. 2014 Oct; 45(10):2094-100.View Related Profiles. PMID: 25130395; DOI: 10.1016/j.humpath.2014.06.018;
  5. Bae-Harboe YS, Park HY. Tyrosinase: a central regulatory protein for cutaneous pigmentation. J Invest Dermatol. 2012 Dec; 132(12):2678-80. PMID: 23187110; DOI: 10.1038/jid.2012.324;
  6. Yaar M, Park HY. Melanocytes: a window into the nervous system. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):835-45.View Related Profiles. PMID: 22158549; DOI: 10.1038/jid.2011.386;
  7. Park HY, Kim JH, Ji JH, Ahn SK, Hong SP. Variant of phacomatosis pigmentokeratotica. J Dermatol. 2011 Jul; 38(7):719-22. PMID: 21352309; DOI: 10.1111/j.1346-8138.2010.01069.x;
  8. Byers HR, Boissel SJ, Tu C, Park HY. RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line. Melanoma Res. 2010 Jun; 20(3):171-8. PMID: 20216103; DOI: 10.1097/CMR.0b013e32832f1581;
  9. Park HY, Wu C, Yaar M, Stachur CM, Kosmadaki M, Gilchrest BA. Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes. Int J Cell Biol. 2009; 2009:750482.View Related Profiles. PMID: 20130821; PMCID: PMC2814237; DOI: 10.1155/2009/750482;
  10. Park HY, Kosmadaki M, Yaar M, Gilchrest BA. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci. 2009 May; 66(9):1493-506.View Related Profiles. PMID: 19153661; DOI: 10.1007/s00018-009-8703-8;
Showing 10 of 25 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 25 publications over 16 distinct years, with a maximum of 3 publications in 2014

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

protein kinase C
signaling pathways
skin cancers
Graduate Education
Faculty development
Faculty mentoring

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
Contact for Mentoring:

72 E. Concord St Instructional (L)
Boston MA 02118
Google Map

Park's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department